0078-0415 : Zortress 0.75 mg Oral Tablet


NDC: 0078-0415
Labeler: Novartis Pharmaceuticals Corporation
Product Type: Human Prescription Drug
Drug Name:  Zortress
Dosage Form: Oral Tablet
Application #: NDA021560
Rev. Date: 


Appearance:


Markings: CL;NVR
Shapes:  Round
Colors:  White
Size (mm): 9
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0078-0415-20: 60 BLISTER PACK IN 1 BOX (0078‑0415‑20) > 1 TABLET IN 1 BLISTER PACK (0078‑0415‑61)

Active Ingredients:

  • Everolimus

Dosage Strength:

  • .75 mg

Inactive Ingredients:

  • Butylated Hydroxytoluene
  • Crospovidone
  • Hypromelloses
  • Anhydrous Lactose
  • Lactose Monohydrate
  • Magnesium Stearate

Pharmaceutical Classes:

  • Kinase Inhibitor [EPC]
  • Protein Kinase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0078-0414 Zortress 0.5 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0417 Zortress 0.25 mg Oral Tablet by Novartis Pharmaceuticals Corporation
  • 0078-0422 Zortress 1 mg Oral Tablet by Novartis Pharmaceuticals Corporation

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0078-0415 QR Code

< Prev: 0078-0414Next: 0078-0417 >

Related Discussions:

Everolimus Face Rash
Side Effects of Everolimus including face and body rash; swollen feet...
Everolimus Side Effects
Everolimus Side Effects: Face and Body Rash...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.